- Previous Close
0.485 - Open
0.510 - Bid 0.475 x --
- Ask 0.520 x --
- Day's Range
0.510 - 0.510 - 52 Week Range
0.450 - 1.050 - Volume
5,000 - Avg. Volume
56,967 - Market Cap (intraday)
266.31M - Beta (5Y Monthly) -0.09
- PE Ratio (TTM)
-- - EPS (TTM)
-0.010 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 15, 2019
- 1y Target Est
--
EPS Creative Health Technology Group Limited, an investment holding company, operates as an apparel supply chain management service provider in Hong Kong, Mainland China, Japan, the United States, Europe, and internationally. The company operates through Garment Business; Healthcare Products Business; and IRO with CRO and In-House R&D Business segments. It offers knitwear products, such as women's, men's, and kid's wear products; and apparel supply chain management solutions for its customers ranging from fashion trend analysis, product design and development, sourcing and procurement of materials, production management, quality control, and logistics services. The company also offers new drugs development, research, licensing and financing support, and medical consultancy services, as well as design and customers account services; and trades in healthcare products. It serves owners or sourcing agents of apparel retail brands. The company formerly known as Speed Apparel Holding Limited and changed its name to EPS Creative Health Technology Group Limited in August 2021. The company was founded in 1999 and is headquartered in Hung Hom, Hong Kong. EPS Creative Health Technology Group Limited is a subsidiary of EPS Holdings, Inc.
www.epshk.hkRecent News: 3860.HK
View MorePerformance Overview: 3860.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3860.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3860.HK
View MoreValuation Measures
Market Cap
266.31M
Enterprise Value
186.35M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.41
Price/Book (mrq)
2.72
Enterprise Value/Revenue
0.29
Enterprise Value/EBITDA
6.70
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.34%
Return on Assets (ttm)
-1.81%
Return on Equity (ttm)
-0.51%
Revenue (ttm)
633.66M
Net Income Avi to Common (ttm)
-2.15M
Diluted EPS (ttm)
-0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
102.31M
Total Debt/Equity (mrq)
30.02%
Levered Free Cash Flow (ttm)
-83.43M